Physician profile
Rachel Wolniewicz
NPI 1962053140
$1,595.94
in general payments reported to CMS, 2019-2025
12 companies · $83.58 in 2025
The $83.58 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $257 · 2022: $273 · 2023: $501 · 2024: $481 · 2025: $83.58.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,066.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,065.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $708.35 | 2021-2025 | Lifevest |
| Boehringer Ingelheim Pharmaceuticals, INC. | $193.69 | 2023-2024 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $129.24 | 2021-2024 | Farxiga |
| Abbott Laboratories | $117.69 | 2023-2024 | Thoratec Heartmate 3 Lvas Implant Kit, Amplatzer Amulet |
| Novartis Pharmaceuticals Corporation | $117.39 | 2021-2022 | |
| Boston Scientific Corporation | $115.38 | 2022 | |
| Kestra Medical Technology Services, INC. | $72.65 | 2023-2024 | Assure Wcd |
| Novo Nordisk INC | $44.87 | 2023-2024 | Ozempic, Rybelsus |
| Janssen Pharmaceuticals, INC | $32.54 | 2022-2023 | Xarelto |
| Pfizer INC. | $29.44 | 2024 | |
| E.R. Squibb & Sons, L.L.C. | $18.36 | 2021 | |
| Alnylam Pharmaceuticals INC. | $16.34 | 2025 | Onpattro |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rachel Wolniewicz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.